Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers

BACKGROUND: The gut microbiome is associated with the response to immunotherapy for different cancers. However, the impact of the gut microbiome on hepatobiliary cancers receiving immunotherapy remains unknown. This study aims to investigate the relationship between the gut microbiome and the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Jinzhu, Wang, Dongxu, Long, Junyu, Yang, Xu, Lin, Jianzhen, Song, Yiwei, Xie, Fucun, Xun, Ziyu, Wang, Yanyu, Wang, Yunchao, Li, Yiran, Sun, Huishan, Xue, Jingnan, Song, Yang, Zuo, Bangyou, Zhang, Junwei, Bian, Jin, Zhang, Ting, Yang, Xiaobo, Zhang, Lei, Sang, Xinting, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650503/
https://www.ncbi.nlm.nih.gov/pubmed/34873013
http://dx.doi.org/10.1136/jitc-2021-003334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650503/
https://www.ncbi.nlm.nih.gov/pubmed/34873013
http://dx.doi.org/10.1136/jitc-2021-003334

Ejemplares similares